Polycystic Liver Disease News and Research

RSS
Scientists highlight advances and uses of organoids in gastroenterology and hepatology

Scientists highlight advances and uses of organoids in gastroenterology and hepatology

Managing autosomal dominant polycystic kidney disease: an interview with Dr Richard Sandford, University of Cambridge

Managing autosomal dominant polycystic kidney disease: an interview with Dr Richard Sandford, University of Cambridge

Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System

Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

Hormone mimic Octreotide promising for treatment of polycystic liver disease caused by ADPKD: Study

Hormone mimic Octreotide promising for treatment of polycystic liver disease caused by ADPKD: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.